Abstract 955: Proteogenomic insights suggest druggable pathways in endometrial cancer

Lizabeth Katsnelson(Institute for Systems Biology), David Fenyö(Institute for Systems Biology), Yongchao Dou(Baylor College of Medicine), Matthew L. Anderson(Institute for Molecular Medicine), Karin Rodland(Oregon Health & Science University), Tao Liu(Cancer Clinic), Bing Zhang(Baylor Genetics)
Cancer Research
April 4, 2023
10.1158/1538-7445.am2023-955
Cited by 0

Related Papers

Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and Chromatin
|Cell|2020|1.2k
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|Cell|2016|1.1k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
|Cell|2019|849